First Showing Of New FDA Leadership Comes In Public Health Emergency
This article was originally published in The Gray Sheet
Executive Summary
With the swine flu outbreak, FDA's new leadership is getting its first real exposure right in the middle of an international public health crisis
You may also be interested in...
People Briefs: FDA Turnover; Appointments At Boston Scientific, Dysis Medical
FDA Chief Scientist Jesse Goodman leaves agency. New FDA deputy commissioner for global regulatory operations and policy appointed. Boston Scientific names new chief medical officer. More people briefs.
State Of The Science At FDA: Catching Up With Jesse Goodman
As the swine flu pandemic shows signs of leveling off, FDA Chief Scientist Jesse Goodman is ready to turn attention back to his original raison d'etre: improving the agency's scientific capacity and integrity
State Of The Science At FDA: Catching Up With Jesse Goodman
As the swine flu pandemic shows signs of leveling off, FDA Chief Scientist Jesse Goodman is ready to turn attention back to his original raison d'etre: improving the agency's scientific capacity and integrity